GB00BMXWN182
GB00BMXWN182
JPMORGAN EMERGING MARKETS GROWT
Loading chart...
Solid Quality Asset with Moderate Fluctuation
Healthy balance: Exemplary business financials (Health Score: 90/100) paired with moderate price swings for a single equity (±18.3% p.a.). The score (5/7) reflects the standard baseline for equities under SRI rules.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
5/7 Elevated
5 / 7 SRI Price Fluctuation & Beta
Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.7x).
Beta (Market Relation)
0.66x
DefensiveVolatility (5Y p.a.)
18.3% p.a.
5-Year HorizonMax Drawdown (5Y)
-32.8%
5-Year HorizonSharpe Ratio
0.18
Return / RiskElevated Risk / Growth: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +27.8% |
| 3 Years | 17.1% | -16.4% | 0.98 | +19.2% |
| 5 Years | 18.3% | -32.8% | 0.18 | +5.7% |
| 10 Years | 19.2% | -39.3% | 0.32 | +8.6% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.